|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 7 July 2009
doi: 10.1242/jcs.049767
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
-dependent apoptosis via ubiquitin-mediated degradation of TRAF2Center for Medicinal Protein Network and Systems Biology, Department of Molecular Medicine and Biopharmaceutical Science, College of Pharmacy, Seoul National University, Seoul 151-742, Korea
* Author for correspondence (e-mail: sungkim{at}snu.ac.kr)
Accepted 28 April 2009
AIMP2 (aminoacyl-tRNA synthetase interacting multifunctional protein 2; also known as JTV-1) was first identified as p38 in a macromolecular protein complex that consisted of nine different aminoacyl-tRNA synthetases and two other auxiliary factors. AIMP2 also plays pivotal roles in the regulation of cell proliferation and death. Although AIMP2 was previously shown to augment TNF
-induced cell death, its working mechanism in this signal pathway was not understood. Here, we investigate the functional significance and mode of action of AIMP2 in TNF
signaling. TNF
-induced cell death was compromised in AIMP2-deficient or -suppressed cells and exogenous supplementation of AIMP2 augmented apoptotic sensitivity to TNF
signaling. This activity was confirmed by the AIMP2-dependent increase of I
B and suppression of NF
B. We found binding of AIMP2 to TRAF2, a key player in the TNF
signaling pathway. AIMP2 augmented the association of an E3 ubiquitin ligase, c-IAP1, with TRAF2, causing ubiquitin-dependent degradation of TRAF2. These findings suggest that AIMP2 can mediate the pro-apoptotic activity of TNF
via the downregulation of TRAF2 expression.
Key words: AIMP2 (p38, JTV-1), Aminoacyl-tRNA synthetase, TNF
signaling
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. W. Choi, J. Y. Um, J. K. Kundu, Y.-J. Surh, and S. Kim Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis Carcinogenesis, September 1, 2009; 30(9): 1638 - 1644. [Abstract] [Full Text] [PDF] |
||||